Drug Shortage Report for SERC
| Report ID | 259254 |
| Drug Identification Number | 02243878 |
| Brand name | SERC |
| Common or Proper name | BETAHISTINE HYDROCHLORIDE |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | BETAHISTINE HYDROCHLORIDE |
| Strength(s) | 16MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 4x25 CA |
| ATC code | N07CA |
| ATC description | ANTIVERTIGO PREPARATIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2025-06-19 |
| Actual start date | |
| Estimated end date | 2025-06-24 |
| Actual end date | 2025-06-16 |
| Shortage status | Avoided shortage |
| Updated date | 2025-06-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-06-17 | French | Compare |
| v3 | 2025-06-17 | English | Compare |
| v2 | 2025-06-04 | French | Compare |
| v1 | 2025-06-04 | English | Compare |
Showing 1 to 4 of 4